Gastroenterology & Hepatology Research (GHR) is a peer-reviewed, Open Access journal dedicated to advancing research in gastroenterology and hepatology. The journal publishes studies on clinical efficacy, mechanisms of action, and theoretical investigations, covering diagnostic, endoscopic, interventional, and therapeutic innovations in cancer, inflammatory diseases, functional gastrointestinal disorders, nutrition, absorption, and secretion. In addition, GHR places a particular emphasis on integrative approaches that combine traditional Chinese medicine (TCM) and Western medicine. The journal encourages submissions exploring the synergistic use of herbal medicine, acupuncture, and other traditional therapies alongside modern biomedical techniques, as well as studies elucidating their mechanisms, clinical effectiveness, and translational potential in gastrointestinal and liver diseases. GHR welcomes original research articles, reviews, editorials, and letters addressing topics such as the alimentary and biliary tracts, gallbladder, liver diseases, hepatitis, hepatocellular carcinoma, peptic ulcers, portal disorders, transplant hepatology, advanced endoscopy, inflammatory bowel disease, and integrative therapeutic strategies in digestive and hepatic disorders.

Gastroenterology & Hepatology Research(GHR) adopts open access publishing model, and all articles are distributed under the terms of the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/). Under this license, anyone may copy, distribute, or reuse these articles for non-commercial purposes, provided the original work is properly cited. Manuscripts submitted for publication in an open access journal are subject to the same rigorous peer-review and quality control as in scholarly subscription journals.

GHR recognizes the distinct advantages of using an open access publication model to timely disseminate innovative and important research findings. Unrestricted free access to our publications is anticipated to foster intellectual discourse across geographic and disciplinary boundaries. To support the success of our open access approach, we ensure the integrity and high quality of research published in our journal by practicing a rigorous peer review process and by following strict guidelines for ethics in publication and in conduct of the scientific process.

All manuscripts submitted to GHR must meet the following criteria for publication:

• Topics with timely relevance to the general field or specialties in basic and clinical medicine;
• A must-have section of “hypothesis/ future direction/ prospect/ prediction” included for all research and review articles;
• Results and findings that have not been previously published elsewhere;
• Research performed with adherence to accepted global standards for ethics in the scientific process;
• Ethical reporting of data to protect the rights and privacy of study participants;
• Appropriate statistical analyses, with sufficient descriptions of all statistical methods used;
• Conclusions supported by the data presented;
• All funding sources and their roles cited;
• For clinical trials, the registration number cited;
• Manuscript written in standard American (US) English and formatted according to the journal-specific guidelines;
• No instances of textual plagiarism, including ‘text recycling/self-plagiarism”.

GHR currently publishes 2 issues a year, in June and December.

GHR Metrics (2025)
Acceptance rate: 60%
Median time from submission to first decision: 35 days

GHR follows an open access publishing model. Revenue is generated through article processing charges, permissions, and reprints. Currently, the publication costs are covered by the publisher.

Editorial Office
Managing Editor: Vivian Xia
E-mail: ighr@xiahepublishing.com
Postal Address: Room 505, Building B1, Bio-innovation Park, No. 666 High-tech Road, East Lake High-tech Development Zone, Wuhan, China

Publisher
Xia & He Publishing Inc.
Website: www.xiahepublishing.com
Tel: +1-409-420-2868
E-mail: service@xiahepublishing.com

US Office
Address: 14090 Southwest Freeway, Suite 300, Sugar Land, Texas 77478, USA

China Office
Address: Room 505, Building B1, Bio-innovation Park, No. 666 High-tech Road, East Lake High-tech Development Zone, Wuhan, China